For the first time, the five EU health and environment agencies – EFSA, ECDC, ECHA, EEA and EMA[1]– supported by the JRC, reviewed how the use of azole substances outside human medicine affects public health.
Azole medicines are essential for treating aspergillosis, a serious infection caused by Aspergillus fungi. However, these fungi are increasingly becoming resistant to azole therapies, making treatment less effective.
Azole substances are widely used in plant protection products (‘pesticides’) to control fungal diseases in agriculture and horticulture, as veterinary medicines to treat fungal…